Asthma Management Handbook

Guidelines Committee members

Amanda Barnard, Australian Asthma Handbook Guidelines Committee Chair

Professor Amanda Barnard (Chair)
General practitioner
Founding member

Professor Amanda Barnard is Associate Dean, Rural Clinical School and Indigenous Health at the Australian National University Medical School. Amanda has practiced as a General Practitioner in both rural and urban areas, and currently continues her clinical work in Braidwood, a small town in NSW. She has a long term interest in asthma and respiratory disease in primary care, being a foundation member of the General Practitioners in Asthma Group of the National Asthma Council Australia. She has written and researched in the area, and is currently a member of the National Monitoring of Asthma and Other Chronic Respiratory Conditions Advisory Group and the General Practice Advisory Group of the Lung Foundation Australia. An awarded teacher and educator, Amanda currently serves on a number of state and national bodies with education, training, rural workforce and health system briefs, and tries to bring a rigorous primary care perspective to her work on them.

Statement of interest

I have been a member of the Lung Foundation Australia GP Advisory Group, Education Sub-committee Member for IPCRG and Mild Asthma Advisory Board member for AstraZeneca.


Dr Ian Almond
General practitioner
Member since 2017

Dr Ian Almond is a General Practitioner based near Hobart, Tasmania. Ian qualified at the Middlesex Hospital in London, served in the British Army, and worked in general practice, screening medicine and occupational health before moving to Tasmania in 2004. Ian was a Board member for the Asthma Foundation of Tasmania for 8 years, has been a part-time respiratory Research Fellow at the Menzies Institute for Medical Research, and is an active member of the state RACGP Board and examiner. He has supervised OTDs and registrars. Ian is a life member of the RCGP in the UK.

Statement of interest

I have no conflicts of interest to declare


Ms Naomi Fenton
Nurse practitioner
Member since 2011

Ms Naomi Fenton is a Registered Nurse and endorsed Nurse Practitioner currently employed in the public and private sectors. Naomi’s scope of practice includes respiratory and allergy nursing. Naomi has post registration and post graduate qualifications and clinical experience in a variety of specialty nursing fields. Naomi works across the acute, outpatient and community settings and has a strong commitment to evidence-based practice and care delivery across the sectors and settings. Naomi is dedicated to health promotion in her local community in line with her scope of practice.

Statement of interest

I have attended meetings funded by AstraZeneca.

Dr Jenny Gowan
Accredited pharmacist
Founding member

Dr Jenny Gowan, a practicing pharmacist, is a Teaching Associate in the Faculty of Pharmacy and Pharmaceutical Sciences, Monash University. She is a member of the Expert Group for Therapeutic Guidelines, Respiratory, and an Editorial Board Member of the AUS-DI Australian Drug Information and SHPA ‘Don’t Rush to Crush’ publications. She is an accredited consultant pharmacist, and conducts her own company focussing on medication reviews in the home and Aged Care Facilities, plus education, training and consultation. Jenny has published over 350 papers and educational articles, and enjoys working in a multidisciplinary environment with general practitioners, nurses, pharmacists and allied health professionals. In 2013 she was awarded the Australian Pharmacist of the Year gold medal by the Pharmaceutical Society of Australia and in 2016 the AACP-MIMs Australian Consultant Pharmacist of the Year.

Statement of interest

I have attended an advisory meeting funded by AstraZeneca. I have done lectures for Teva.

Professor Adam Jaffé
Paediatric respiratory physician
Member since 2016

Professor Adam Jaffé BSc (Hons) MBBS MD FRCP FRCPCH FRACP FThorSoc is the John Beveridge Professor of Paediatrics, Head, School of Women's and Children's Health at UNSW and Associate Director of Research for the Sydney Children's Hospitals Network (Randwick). He is also a Paediatric Respiratory Consultant at the Sydney Children's Hospital, Randwick. Professor Jaffé was appointed to Consultant in Respiratory Research at Great Ormond Street Hospital for Children, London and headed up Respiratory Medicine Research at the Institute of Child Health London before moving to Sydney in 2006. His interests lie in the areas of asthma, cystic fibrosis, childhood respiratory infections and rare “orphan” lung diseases. His research career centres around translational research specifically aimed at improving child health outcomes. Professor Jaffé has published in excess of 170 peer reviewed publications and 18 book chapters, and has been associated with more than $12 million in grant awards including 2 current NHMRC grants as Chief Investigator. 

Statement of interest

I have attended meetings sponsored by GlaxoSmithKline.

Professor Helen Reddel
Adult respiratory physician
Founding member

Professor Helen Reddel is a respiratory physician primarily working in primary care research and guidelines relating to asthma and COPD. Prof. Reddel is a Research Leader at the Woolcock Institute of Medical Research at University of Sydney, Chair of the Science Committee of the Global Initiative for Asthma (GINA), and Clinical Adviser for the Australian Centre for Airways disease Monitoring (ACAM). Prof. Reddel’s current research focusses on practical strategies to improve the management of asthma and COPD through better guidelines, diagnosis, assessment, prescribing, adherence and inhaler technique; collaborative approaches to the management of airways disease with pharmacists, practice nurses and general practitioners; and population level monitoring of asthma and COPD. Prof. Reddel has a strong focus on the patient perspective and on improving communication between patients and health professionals. She has been closely involved in major revisions of Australian and international asthma guidelines.

Statement of interest

I have provided independent expert advice on advisory/data safety monitoring boards for AstraZeneca, GlaxoSmithKline, Merck, Novartis, Boehringer-Ingelheim and Sanofi Genzyme. I am a member of AstraZeneca's steering committee for clinician-initiated pharma-funded research study. I have consulted for AstraZeneca and GlaxoSmithKline. I have provided independent medical education for AstraZeneca, GlaxoSmithKline, Novartis, Boehringer-Ingelheim, Teva and Mundipharma. I have attended meetings funded by AstraZeneca, GlaxoSmithKline, Novartis, Boehringer-Ingelheim and Teva. I have received grants for investigator-sponsored research from AstraZeneca and GlaxoSmithKline.

Associate Professor Janet Rimmer
Allergist and respiratory physician
Founding member

Associate Professor Janet Rimmer is a respiratory physician and allergist who trained in Australia including undertaking an MD thesis entitled "Histamine releasability in asthma" at the Garvan Institute in Sydney. She then undertook further research and clinical training overseas (Professor Steven Holgate's group at the Department of Immunopharmacology, Southampton and the Brompton Hospital, London). She is primarily a clinician and has VMO positions at St Vincent's Private, RPAH, Wolper Hospital, St Lukes Hospital.

She also works as a Senior Medical Officer at the Dust Diseases Board of NSW. She has run a private medical practice at St Vincent's Clinic for 26 years. She has been involved in professional organisations including the Australasian Society of Clinical Immunology and Allergy (NSW State President, National Honorary Secretary, Treasurer ICACI), Thoracic Society of Australia and New Zealand (Convenor of the Asthma and Allergy SIG), National Asthma Council (Director and ASCIA representative), St Vincent's Clinic (Chair of the Medical Council and Board), St Vincent's Private Hospital (Chair Medical Credentials Committee, member of the Medical Advisory Committee) and member of the SVHA Sydney Regional Advisory Council and  Sydney Hospital (Honorary Secretary Department of Medicine and Chair Combined Medical Staff Council, representative at the Northern Health Clinical Council).

Statement of interest

I have been a member of an advisory board for Stallergenes. I have done lectures for GlaxoSmithKline. I have undertaken Mapi Trust questionnaire distribution. I have paid costs to AICD (Australian Institute of Company Directors) as Board Chair, St Vincents Clinics.

Professor Peter Wark
Adult respiratory physician
Founding member

Professor Peter Wark is a senior staff specialist in Respiratory and Sleep Medicine at John Hunter Hospital, Newcastle and a conjoint Professor with the University of Newcastle. In addition he is co-director of the priority research centre for asthma and respiratory disease and a member of the Vaccines Immunology Viruses and Asthma research group at the Hunter Medical Research Institute. He has been a member of the Thoracic Society of Australia and New Zealand (TSANZ) executive board since and chairman of the clinical care and resources subcommittee since 2011. His research interests are in the area of infection and the impact this has on inflammatory airways disease, with a particular interest in viral respiratory infections. His group has developed expertise in identifying respiratory viruses in airway secretions and developing an in-vitro cell culture model of the airway epithelium that we use to model the effect of infection and inflammation. He is the Centre Director for the John Hunter Adult Cystic Fibrosis clinic and chairperson for the Hunter New England Local Hospital network respiratory stream.

Statement of interest

I am a member of the Thoracic Society of Australia and New Zealand (TSANZ). I have consulted for AstraZeneca, GlaxoSmithKline, Boehringer-Ingelheim and Sanofi-Roche. I have previously received funding from AstraZeneca and GlaxoSmithKline for speaking engagements. I have received funding in the form of grants from Novartis and GlaxoSmithKline.

Updated March 3019

Past members

Special acknowledgement: Professor Peter van Asperen

Professor Peter van Asperen was a founding member of the Guidelines Committee, providing the paediatric respiratory physician perspective for Versions 1.0 and 1.1. He also co-chaired the paediatric working group alongside Professor Adam Jaffé.

Professor van Asperen was a highly respected paediatric respiratory physician who had a long relationship with the National Asthma Council Australia as a trusted colleague and advisor for more than 20 years. He was Macintosh Professor of Paediatric Respiratory Medicine & Acting Associate Dean, The Children’s Hospital at Westmead (CHW) Clinical School, Sydney Medical School, University of Sydney and Senior Staff Respiratory Physician in the Department of Respiratory Medicine at CHW. He had an active clinical and research interest in childhood asthma and children with recurrent and persistent cough. He published over 160 papers as well as two books for families of children and young people with asthma. He was on the Board of the Asthma Foundation of NSW from 2002–2010. He was also involved as co-author on position papers and guidelines for management of asthma and cough in children. 

Professor van Asperen passed away in 2015. Alongside his clinical acumen, Peter's kindness and generosity will be long remembered, as well as his commitment to education, mentoring and good medicine. Indeed, he insisted on being involved in the Handbook version 1.1 update despite his own health situation. We are indebted to him for his contribution.


Version 1.1

Dr Gary Kilov, general practitioner (2014–15)

Professor Peter van Asperen, paediatric respiratory physician (2010–15)


Version 1.0

Ms Anna Berkelmans, asthma and respiratory educator (2010–11)

Dr Jane Marr, general practitioner (201214)

Dr David Sutherland, general practitioner (201011)

Professor Peter van Asperen, paediatric respiratory physician (2010–15)